Quality of life in type 2 diabetes patients under intensive multitherapy

Diabetes and Metabolism

Volumn 33, Issue 1, 2007, Pages 54-60

  Menard J ^a   Payette, H ^b   Dubuc, N ^b   Baillargeon, J P ^a   Maheux, P ^a   Ardilouze, J L ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

Author keywords

Intensive multitherapy; Quality of life; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; AGED; ANXIETY; ATTITUDE TO HEALTH; BLOOD; DRUG COMBINATION; FEMALE; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT;

ADULT; AGED; ANXIETY; ATTITUDE TO HEALTH; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34247275782     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2006.09.001     Document Type: Article

References (37)

1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 352 (1998) 837-853
2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317 (1998) 703-713
3. Haffner S.M., Alexander C.M., Cook T.J., et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch. Intern. Med. 159 (1999) 2661-2667
4. Gaede P., Vedel P., Parving H.H., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
5. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can. J. Diabetes 27 (2003) S1-S140
6. American Diabetes Association. 2005 Clinical Practice Recommendations. Diabetes Care 28 (2005) S1-S79
7. Rubin R.R., and Peyrot M. Quality of life and diabetes. Diabetes Metab. Res. Rev. 15 (1999) 205-218
8. Glasgow R.E., Ruggiero L., Eakin E.G., et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 20 (1997) 562-567
9. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control: UKPDS 37. Diabetes Care 22 (1999) 1125-1136
10. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
11. Adler A.I., Stratton I.M., Neil H.A., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321 (2000) 412-419
12. Menard J., Payette H., Baillargeon J.P., et al. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial. CMAJ 173 (2005) 1457-1466
13. Guillemin F., Bombardier C., and Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol. 46 (1993) 1417-1432
14. Spiker B. Quality of life and pharmacoeconomics in clinical trials (1996), Lippincott-Raven, Philadelphia
15. The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 11 (1988) 725-732
16. Renard E., Apostol D., Lauton D., et al. Quality of life in diabetic patients treated by insulin pumps. QoL Newsletter 28 (2002) 11-13
17. The DCCT Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 19 (1996) 195-203
18. Jacobson A.M., de Groot M., and Samson J.A. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 17 (1994) 267-274
19. Dunn S.M., Smartt H.H., Beeney L.J., et al. Measurement of emotional adjustment in diabetic patients: validity and reliability of ATT39. Diabetes Care 9 (1986) 480-489
20. Dunn S.M., Bryson J.M., Hoskins P.L., et al. Development of the diabetes knowledge (DKN) scales: forms DKNA, DKNB, and DKNC. Diabetes Care 7 (1984) 36-41
21. Johnson S.B. Methodological issues in diabetes research: Measuring adherence. Diabetes Care 15 (1992) 1658-1667
22. Glasgow R.E., Wilson W., and McCaul K.D. Regimen adherence: a problematic construct in diabetes research. Diabetes Care 8 (1985) 300-301
23. Dillman D.A. Mail and telephone surveys: The total design method (1978), John Wiley and Sons, New York
24. Kandrack M.A., Grant K.R., and Segall A. Gender differences in health related behaviour: some unanswered questions. Soc. Sci. Med. 32 (1991) 579-590
25. Davis W.K., Hess G.E., Van Harrison R., et al. Psychosocial adjustment to and control of diabetes mellitus: differences by disease type and treatment. Health Psychol. 6 (1987) 1-14
26. Hanestad B.R. Self-reported quality of life and the effect of different clinical and demographic characteristics in people with type 1 diabetes. Diabetes Res. Clin. Pract. 19 (1993) 139-149
27. Contandriopoulos A.P., Champagne F., Potvin L., Denis J.L., and Boyle P. Savoir préparer une recherche : la définir, la structurer, la financer (1990), Les Presses de l'Université de Montréal, Montréal
28. Fleiss J.L. The design and analysis of clinical experiments (1986), John Wiley and Sons, Inc, New York
29. Vallerand R.J. Vers une méthodologie de validation trans-culturelle de questionnaires psychologiques : implications pour la recherche en langue française. Psychologie canadienne 30 (1989) 662-679
30. Koro C.E., Bowlin S.J., Bourgeois N., et al. Glycemic control form 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27 (2004) 17-20
31. Bradley C., and Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab. Res. Rev. 18 (2002) S64-S69
32. Clement S. Diabetes self-management education. Diabetes Care 18 (1995) 1204-1214
33. Rose M., Burkert U., Scholler G., et al. Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 21 (1998) 1876-1885
34. Lockington T.J., Farrant S., Meadows K.A., et al. Knowledge profile and control in diabetic patients. Diabet. Med. 5 (1988) 381-386
35. de Sonnaville J.J., Snoek F.J., Colly L.P., et al. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care 21 (1998) 919-924
36. Goddijn P.P., Bilo H.J., Feskens E.J., et al. Longitudinal study on glycaemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control. Diabet. Med. 16 (1999) 23-30
37. Assal J.P., Muhlhauser I., Pernet A., et al. Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28 (1985) 602-613